Tradestie Institutional Equity Comparison Engine

EVMN vs ANNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EVMN Overall Edge

EVMN Captures Institutional Edge (2โ€“1 Pillars ยท 1โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Growth & Margin, Options & Structure while ANNX counters with relative strength in Momentum & Technical. Fundamentally, EVMN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ANNX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EVMN sits in SURGE (53rd %ile IV; Dealer Gamma Walls on Pro) against ANNX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EVMN N/M vs ANNX N/M Fwd P/E
Growth & Margin Winner EVMN
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner ANNX
1Y -61.0% vs +33.2% ยท 52W Pos 8% vs 22%
Options & Structure Winner EVMN
SURGE (53rd %ile IV) vs BREAKDOWN (100th %ile IV)
EVMN US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.10
-6.95% 1D
Market Cap $315.5M
1M Return +37.33%
1Y Return -61.03%
Forward P/E N/M
Unified AI Score
30.0 / 100 SELL
Tech 50.0 Fund 35.0 Flow 69.0 Mom 44.0
ANNX NASDAQ
Annexon, Inc. Common Stock
Pharmaceutical Preparations
$3.57
-8.93% 1D
Market Cap $747.8M
1M Return +4.69%
1Y Return +33.21%
Forward P/E N/M
Unified AI Score
44.6 / 100 HOLD
Tech 42.0 Fund 54.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EVMN -61.03% ANNX +33.21% Spread: +94.24 pp (ANNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EVMN TTM Op. Margin: 0.0% ANNX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVMN vs ANNX. Trailing 12-month operating profitability (EVMN 0.0% vs ANNX 0.0%) and valuation multiples (EVMN N/M vs ANNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EVMN (1) vs ANNX (4)
Institutional Metric EVMN ANNX Criterion Row Winner
Market Capitalization Scale $315.5M $747.8M Larger Scale ANNX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -69.5% -130.8% Higher ROE EVMN
52-Week Range Position Momentum 8% ($5โ€“$33) 22% ($3โ€“$7) Stronger Trend ANNX
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 118% Vol 1.68ฮฒ ยท 62% Vol Lower Realized Risk ANNX
Unified Institutional Score Composite Signal 30.0 / 100 (SELL) 44.6 / 100 (HOLD) Higher Composite ANNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EVMN vs ANNX Buy Guide
EVMN SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EVMN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANNX BREAKDOWN
87d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ANNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EVMN nor ANNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.